ArticleInternational journal of surgery case reports2025
Case report: Granulocytopenia induced by local injection of MTX for abdominal pregnancy.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A rare case report of successful surgical treatment of diaphragmatic pregnancy after chemotherapy.Frontiers in reproductive health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAbdominal ectopic pregnancies(APs) is a rare type of ectopic pregnancy, most commonly implanting in the rectouterine pouch. The treatment methods include surgical treatment and drug therapy. In the surgical treatment of ectopic pregnancy, local injection of methotrexate(MTX)at the site of pregnancy can reduce the occurrence of persistent ectopic pregnancy(PEP). However, there is no unified standard for the treatment dosage. We report a case of an AP patient who received local injection of MTX during surgery and developed neutropenia postoperatively. PRESENTATION OF CASE: A 29-year-old woman with a 45-day history of missed menses and rectal pressure presented with suspected ruptured ectopic pregnancy. Intraoperative exploration revealed no abnormalities in the appearance of both ovaries and fallopian tubes. Upon careful examination, the pregnancy tissue was found to be located on the inner side of the right sacral ligament and the pregnancy tissue was removed. To prevent the occurrence of PEP, MTX was locally injected at a dose of 50 mg/m DISCUSSION: APs is a rare form of ectopic pregnancy that can be treated with laparoscopy in the early stages of pregnancy. It is well known that local injection of MTX at the site of pregnancy during surgery can reduce the occurrence of PEP. There are documented cases of local MTX injection reducing the occurrence of PEP in special locations such as retroperitoneal pregnancy and cervical pregnancy. However, there is no unified standard for the therapeutic dosage. The minimum effective dose of locally injected MTX to prevent PEP needs further exploration. There have been no reports on the occurrence of granulocytopenia due to the local injection of MTX during surgery for ectopic pregnancy to prevent the PEP.
conclusionEctopic pregnancy patients, such as those with abdominal pregnancy, if treated with a combination of local MTX injection during surgery, require close postoperative monitoring of blood routine. The minimum effective dose still needs further exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.